Oxford BioDynamics installs new SVP of Commercial Development
March 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics
Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …
Researchers find common protein link between cancer and autism
March 10, 2017Medical Communications Cancer, SHANK, University of Turku, autism
Researchers from the University of Turku, in Finland, have discovered that there is a common protein, named SHANK, that is …
Top Ten most popular articles on Pharmafile.com this week
March 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
The past week in the industry has brought much hope for patients with the news of significant research data developments …
Breakthrough discovery could lead to new targeted cancer treatment
March 10, 2017Medical Communications Cancer, The Scripps Research Institute
Research conducted by The Scripps Research Institute has unearthed a potential treatment for those with prostate and breast cancer that …
Closure of Scottish J&J plant threatens 400 staff
March 10, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson has announced its intention to shut down its surgical suture manufacturing facility in Livingston, Scotland which sees …
Patient engagement is key to building a biosimilar market
March 10, 2017Medical Communications Clarivate analytics, biosimilars
There’s a whole lot of explaining to do before many U.S. patients and doctors will feel comfortable with biosimilars in …
Amgen accuses biosimilar producer of ‘massive conspiracy’
March 9, 2017Medical Communications Amgen, Coherus, Neulasta, biosimilars
Amgen has filed a lawsuit in a Californian state court against Coherus Biosciences, suggesting that Coherus had stolen trade secrets. …
BMS finds replacement for retiring CSO
March 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb
Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
Cambridge University announces ‘world-leading’ industry-academia collaboration initiative
March 9, 2017Medical Communications, Research and Development University of Cambridge
The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …
Novo Nordisk eyes acquisition of Global Blood Therapeutics
March 9, 2017Sales and Marketing Global Blood Therapeutics, Novo Nordisk
Novo Nordisk has been notoriously shy when it comes to making acquisitions but Reuters has reported that this may be …
13 FDA observations on Dr Reddy’s plant send shares to 3 year low
March 9, 2017Manufacturing and Production Dr Reddy's, FDA
Indian pharmaceutical firm Dr Reddy’s has seen its shares drop on the Bombay Stock Exchange to their lowest point in …
Looming Brexit sparks fears for child cancer trials, experts warn
March 9, 2017Medical Communications, Research and Development EU, ICR, brexit
The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …
Keapstone Therapeutics created out of Sheffield Uni and Parkinson’s UK link
March 8, 2017Research and Development Keapstone therapeutics, Parkinson's UK, University of Sheffield
The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for developing therapies against …
New drug combination gives hope for acute myeloid leukaemia treatment
March 8, 2017Research and Development acute myeloid leukaemia
A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …
Vectura’s COO set to step down
March 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura
Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
FDA and NICE approve of first new hyperparathyroidism drug in 12 years
March 8, 2017Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism
The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …
Diabetes drug could be key to treating aggressive breast cancer, research suggests
March 8, 2017Research and Development Cancer, diabetes
Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
Research gives hope of potential treatment for most deadly paediatric brain tumour
March 8, 2017Research and Development
A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …
BeiGene to develop $330 million biologics plant
March 7, 2017Manufacturing and Production, Research and Development BeiGene, China, Guangzhou
BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
Researchers discover worrying new antibiotic-resistance gene variant
March 7, 2017Manufacturing and Production, Research and Development drug resistance
A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
